logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Silodosin CAS 160970-54-7 API Active Pharmaceutical Ingredient

Silodosin CAS 160970-54-7 API Active Pharmaceutical Ingredient

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 160970-54-7

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:

Silodosin CAS 160970-54-7

,

CAS 160970-54-7

Appearance::
White To Off-white Solid
CAS NO::
160970-54-7
Molecular Formula::
C25H32F3N3O4
Molecular Weight::
495.53400
EINECS NO::
814-909-2
MDL NO::
MFCD00930170
Appearance::
White To Off-white Solid
CAS NO::
160970-54-7
Molecular Formula::
C25H32F3N3O4
Molecular Weight::
495.53400
EINECS NO::
814-909-2
MDL NO::
MFCD00930170
Silodosin CAS 160970-54-7 API Active Pharmaceutical Ingredient

Product Description:

Product Name: Silodosin CAS NO: 160970-54-7


Synonyms:

2,3-dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carboxamide;

KAD 3213;

1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide;


Chemical & Physical Properties:

Appearance: White to off-white solid

Assay :≥99.00%

Density: 1.249g/cm3

Boiling Point: 601.4℃ at 760 mmHg

Flash Point: 317.5℃

Refractive Index: 1.552

Vapor Pressure: 2.58E-15mmHg at 25℃


Safety Information:

HS Code: 29339900


Silodosin (trade names Rapaflo (USA), Silodyx (Europe and South Africa), Rapilif (India), Silodal (India), Urief (Japan), Urorec (Russia)) is a medication for the symptomatic treatment of benign prostatic hyperplasia. It acts as an α1-adrenoceptor antagonist with high uroselectivity (selectivity for the prostate). Cilodoxine is an alpha1A-adrenergic receptor antagonist. It is used to treat benign enlargement of the prostate.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.